LEADER 02560nam 2200517 450 001 9910138286803321 005 20221014072646.0 010 $a953-51-4421-9 035 $a(CKB)3230000000076312 035 $a(NjHacI)993230000000076312 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/50664 035 $a(MiAaPQ)EBC30390229 035 $a(Au-PeEL)EBL30390229 035 $a(EXLCZ)993230000000076312 100 $a20221014d2011 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aIonic liquids $eclasses and properties /$fedited by Scott T. Handy 205 $a1st ed. 210 $cIntechOpen$d2011 210 1$aRijeka, Crotia :$cIntechOpen,$d[2011] 210 4$dİ2011 215 $a1 online resource (xiv, 344 pages) $cillustrations 311 $a953-307-634-8 320 $aIncludes bibliographical references. 330 $aRoom temperature ionic liquids (RTILs) are an interesting and valuable family of compounds. Although they are all salts, their components can vary considerably, including imidazolium, pyridinium, ammonium, phosphonium, thiazolium, and triazolium cations. In general, these cations have been combined with weakly coordinating anions. Common examples include tetrafluoroborate, hexafluorophosphate, triflate, triflimide, and dicyanimide. The list of possible anionic components continues to grow at a rapid rate. Besides exploring new anionic and cation components, another active and important area of research is the determinination and prediction of their physical properties, particularly since their unusual and tunable properties are so often mentioned as being one of the key advantages of RTILs over conventional solvents. Despite impressive progress, much work remains before the true power of RTILs as designer solvents (i.e. predictable selection of a particular RTIL for any given application) can be effectively harnessed. 517 $aIonic liquids 606 $aIonic solutions$xProperties 610 $aPhysical Sciences 610 $aEngineering and Technology 610 $aMaterials Science 610 $aFluid Dynamics 610 $aFluid Mechanics 615 0$aIonic solutions$xProperties. 676 $a541.372 700 $aScott T. Handy$4auth$01363961 702 $aHandy$b Scott T. 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910138286803321 996 $aIonic liquids$93385043 997 $aUNINA LEADER 03069nam 2200625 a 450 001 9910818185103321 005 20240514074538.0 010 $a9786613333148 010 $a9781119962205 010 $a111996220X 010 $a9781119962175 010 $a111996217X 010 $a9781283333146 010 $a1283333147 010 $a9781119962182 010 $a1119962188 035 $a(CKB)4330000000002627 035 $a(MiAaPQ)EBC822598 035 $a(Au-PeEL)EBL822598 035 $a(CaPaEBR)ebr10512932 035 $a(CaONFJC)MIL333314 035 $a(OCoLC)768732452 035 $a(Perlego)1013891 035 $a(EXLCZ)994330000000002627 100 $a20110610d2012 uy 0 101 0 $aeng 135 $aurcn||||||||| 181 $2rdacontent 182 $2rdamedia 183 $2rdacarrier 200 00$aClinical dilemmas in primary liver cancer /$fedited by Roger Williams, Simon D. Taylor-Robinson 205 $a1st ed. 210 $aChichester, West Sussex $cJohn Wiley & Sons$d2012 215 $ax, 218 p., [7] p. of plates $cill. (some col.), col. map 311 08$a9780470657973 311 08$a0470657979 320 $aIncludes bibliographical references and index. 327 $apt. 1. Learning from a worldwide perspective -- pt. 2. Influence of tumor characteristics -- pt. 3. Complexities of patient assessment and scoring systems -- pt. 4. Choice of radiological diagnostic technique -- pt. 5. Can treatment be tailored to the patient? -- pt. 6. What does the future hold?. 330 8 $aClinical Dilemmas in Liver Cancer follows the successful format of the other books in the Clinical Dilemmas series, with each chapter focused on a specific dilemma, or issue facing doctors in their day-to-day job, and providing them with practical clinical information and help to better assessment and treat their patients - in this case patients suffering from liver cancer, the third commonest cancer in terms of mortality worldwide. Chapters feature up-to-date information on the basic mechanisms, epidemiological risk factors, screening and surveillance strategies, diagnosis and treatment. It is an extremely practical and clinically-orientated book, and as most patients around the world present with advanced disease, a main focusis on the most recent advances allowing early diagnosis and use of locoregional and systemic therapy, surgery, transplantation and combination therapies. Each chapter is authored by an international expert in the relevant area. 606 $aLiver$xCancer 606 $aLiver$xCancer$xDiagnosis 606 $aLiver$xCancer$xTreatment 615 0$aLiver$xCancer. 615 0$aLiver$xCancer$xDiagnosis. 615 0$aLiver$xCancer$xTreatment. 676 $a616.99/436 701 $aWilliams$b Roger$f1931-$01600992 701 $aTaylor-Robinson$b Simon D$01600993 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910818185103321 996 $aClinical dilemmas in primary liver cancer$93924381 997 $aUNINA